Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Zur Hypothese eines cholinergen Wirkungsmechanismus des Morphins

  • 12 Accesses

  • 7 Citations

This is a preview of subscription content, log in to check access.

Literatur

  1. Aldridge. W. N.: Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl-p-nitrophenyl thiophosphate (E 605) and analogues. Biochem. J. 46, 451 (1950).

  2. Andrews. H. L.: The effect of morphine and prostigmine methylsulfate on measurements of pain threshold. J. Amer. med. Ass. 120, 525 (1942).

  3. Blohm. T. R., and W. G. Willimore: Effects of N-allyl-normorphine on cholinesterases. Proc. Soc. exp. Biol. (N. Y.) 77, 718 (1951).

  4. De Jongh. D. K.: Remarks on the mechanism of analgestic action of morphine. Acta physiol. pharmacol. neerl. 3, 164 (1954).

  5. Dirnhuber. P., and H. Cullumbine: The effect of anti-cholinesterase agents on the rat's blood pressure. Brit. J. Pharmacol. 10, 12 (1955).

  6. DuBois. K. P., J. Doull, P. R. Salerno and J. M. Coon: Studies on the toxicity and mechanism of action of p-nitrophenyl diethyl thionophosphate (parathion). J. Pharmacol. exp. Ther. 95, 79 (1949).

  7. DuBois. K. P., W. F. Erway and R. U. Byerrum: A comparison of cholinesterase inhibitors in vitro and in vivo. Fed. Proc. 6, 326 (1947).

  8. Eadie. G. S.: The inhibition of cholinesterase by morphine in vitro. J. biol. Chem. 138, 597 (1941).

  9. Frawley. J. P., E. C. Hagan and O. G. Fitzhugh: A comparative pharmacological and toxicological study of organic phosphate anticholinesterase compounds. J. Pharmacol. exp. Ther. 105, 156 (1952).

  10. Goldstein. A.: The mechanism of enzyme-inhibitor-substrate reactions, illustrated by the cholinesterase-physostigmine-acetylcholine system. J. gen. Physiol. 27, 529 (1944).

  11. Gordonoff, T., u. E. L. Ehrlich: Analgesie und vegetatives Nervensystem. Helv. physiol. pharmacol. Acta 14, 22 C (1956).

  12. Haffner, F.: Experimentelle Prüfung schmerzstillender Mittel. Dtsch. med. Wschr. 1929, 731.

  13. Hagan. E. C., and G. Woodard: Toxicological properties of hexaethyl tetraphosphate. Fed. Proc. 6, 335 (1947).

  14. Herken. H., D. Maibauer u. S. Müller: Acetylcholingehalt des Gehirns und Analgesie nach Einwirkung von Morphin und einigen 3-Oxymorphinanen. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 230, 313 (1957).

  15. Hobbiger. F.: Inhibition of cholinesterases by irreversible inhibitors in vitro and in vivo. Brit. J. Pharmacol. 6, 21 (1951).

  16. Holtz. P., H. Balzer u. E. Westermann: Beeinflussung der Narkosedauer durch Hemmung der Cholinesterase des Gehirns. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 233, 438 (1958).

  17. Knoll. J., E. Komlós u. J. Pórszász: Analgesie und Cholinesterasehemmung. Acta physiol. Acad. Sci. hung. 2, 479 (1951).

  18. Koelle. G. B.: Protection of cholinesterase against irreversible inactivation by di-isopropyl fluorophosphate in vitro. J. Pharmacol. exp. Ther. 88, 232 (1946).

  19. Koelle. G. B., and E. C. Steiner: The cerebral distribution of a tertiary and a quarternary anticholinesterase agent following intravenous and intraventricular injection. J. Pharmacol. exp. Ther. 118, 420 (1956).

  20. Komlós. E., u. V. Komlós-Szasz: Die Rolle der Leber im Synergismus der Analgetika und Parasympathicomimetika I. Acta physiol. Acad. Sci. hung. 6, 443 (1954).

  21. Komlós. E., u. V. Komlós-Szasz: Die Rolle der Leber im Synergismus der Analgetika und Parasympathicomimetika II. Acta physiol. Acad. Sci. hung. 6, 451 (1954).

  22. Komlós. E., J. Pórszász u. J. Knoll: Morphin-Prostigmin Synergismus. Acta physiol. Acad. Sci. hung. 1, 77 (1950).

  23. Koster. R.: Synergisms and antagonisms between physostigmine and di-isopropyl fluorophosphate in cats. J. Pharmacol. exp. Ther. 88, 39 (1946).

  24. Litchfield. J. T., and F. Wilcoxon: A simplified method of evaluating dose-effect experiments. J. Pharmacol. exp. Ther. 96, 99 (1949).

  25. Pórszász. J., J. Knoll u. E. Komlós: Wirkung der Parasympathomimetika auf die Analgesie. Acta physiol. Acad. Sci. hung. 2, 469 (1951).

  26. Randall. L. O., J. Kruger, C. Conroy, B. Kappell and W. M. Benson: Peripheral effects of the optical antipodes of 3-hydroxy-N-methyl-morphinan and some of their derivatives. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 220, 26 (1953).

  27. Saxena. P. N.: Mechanism of cholinergic potentiation of morphine analgesia Indian J. med. Res. 46, 653 (1958).

  28. Schaumann. O.: Some new aspects of the action of morphine-like analgesics. Brit. med. J. 11, 1091 (1956).

  29. Schaumann. W.: Antagonistische Wirkung von Morphin und Cholinesterase-Hemmern auf das Atemzentrum. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 233, 98 (1958).

  30. Schaumann. W., and C. Job: Differential effects of a quarternary cholinesterase inhibitor, phospholine, and its tertiary analogue, compound 217-AO, on central control of respiration and on neuromuscular transmission. The antagonism by 217-AO of the respiratory arrest caused by morphine. J. Pharmacol. exp. Ther. 123, 114 (1958).

  31. Siegmund. P., u. M. Wolf: Eine einfache Methode der Motilitätsmessung an Mäusen. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 216, 323 (1952).

  32. Slaughter. D., and E. G. Gross: Some new aspects of morphine action, effect on intestine and blood pressure; toxicity studies. J. Pharmacol. exp. Ther. 68, 96 (1940).

  33. Slaughter. D., and R. W. Lackey: Effect of morphine on serum cholinesterase. Proc. Soc. exp. Biol. (N. Y.) 45, 8 (1940).

  34. Slaughter. D., and D. W. Munsell: Some new aspects of morphine action. Effects on pain. J. Pharmacol. exp. Ther. 68, 104 (1940).

  35. Slaughter. D., J. C. Parsons and H. D. Munal: New clinical aspects of the analgesic action of morphine. J. Amer. med. Ass. 115, 2058 (1940).

  36. Stöckli. H. W., u. K. Fromherz: Pharmakologische Wirkungen des Dihydrodesoxymorphin-D (Permonid-Roche) im Vergleich zu Morphin. Helv. physiol. pharmacol. acta 3, 335 (1945).

  37. Straus. O. H., and A. Goldstein: Zone behaviour of enzymes. Illustrated by the effect of dissociation constant and dilution on the system cholinesterase-physostigmine. J. gen. Physiol. 26, 559 (1943).

  38. Szerb. J. C.: Interaction of cholinesterase inhibitors with morphine and levallorphan. Arch. int. Pharmacodyn. 111, 314 (1957).

  39. Young. D. C., R. A. Van der Ploeg, R. M. Featherstone and E. G. Gross: The interrelationships among the central, peripheral and anticholinesterase effects of some morphinan derivatives. J. Pharmacol. exp. Ther. 114, 33 (1955).

Download references

Author information

Additional information

Herrn Professor Dr. W. S. Loewe, Salt Lake City, zum 75. Geburtstag gewidmet.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schaumann, W. Zur Hypothese eines cholinergen Wirkungsmechanismus des Morphins. Naunyn - Schmiedebergs Arch 237, 229–240 (1959). https://doi.org/10.1007/BF00244731

Download citation